Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?
Chronic rejection has been the major obstacle to the long-term allograft survival in the clinic. Although the etiology of this rejection reaction is multifactorial, alloantigen-specific immune activation plays the most critical role. We herein hypothesize that CD4+ Th2 cells that are preferentially induced by the indirect recognition of allogeneic histocompatibility antigens late in transplantation may play the most critical role in the initiation and/or maintenance of chronic allograft rejection. Immunosuppression used to prevent acute rejection and the nature of antigen-presenting cells and alloligands in the graft may all contribute to immune deviation to the Th2 response. This response may be further perpetuated by type 2 cytokines conceivably produced by activated macrophages, NK cells, and CD8+ T cells in the graft. Cytokines and growth factors induced by this type 2 response, in turn, allow for activation of B, endothelial, and smooth muscle cells that collectively contribute to the pathogenesis of chronic allograft rejection by producing alloantibodies and growth hormones required for interstitial fibrosis, extracellular matrix deposition, and vascular neointimal hyperplasia.
Shirwan
H
H
Institute for Cellular Therapeutics, School of Medicine, University of Louisville, Kentucky 40292, USA.
D000938:Antigen-Presenting Cells / Q000502:physiology; D002908:Chronic Disease; D006084:Graft Rejection; D006801:Humans; D007519:Isoantigens / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology / Q000502:physiology; D014184:Transplantation, Homologous / Q000276:immunology
D007519:Isoantigens